LUMICKS
About:
LUMICKS provides single-molecule analysis technologies for cancer research and immunotherapy.
Website: https://lumicks.com
Twitter/X: LUMICKS_nl
Top Investors: European Investment Bank, T. Rowe Price, SoftBank Vision Fund, Lauxera Capital Partners, Irving Investors
Description:
LUMICKS delivers state-of-the-art technologies for the study of biology and cancer at the single-molecule and single-cell levels. It aims to build the unfinished bridge between structure and function at the molecular and cellular levels. Using its product C-Trap Optical Tweezers, Fluorescence Microscopy, scientists are able to analyze complex biological processes in real-time. Similarly, the z-Movi Cell Avidity Analyzer enables the measurement and selection of immune cells based on their real-time interactions with target cells.
97.9M EUR
$1M to $10M
Amsterdam, Noord-Holland, The Netherlands
2014-03-01
info(AT)lumicks.com
Andrea Candelli, Olivier Heyning
101-250
2024-10-10
Private
© 2025 bioDAO.ai